BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6293112)

  • 1. Regulation of the immune response to antigens on the malignant cell surface.
    Drebin JA; Perry LL; Carter R; Greene MI
    Springer Semin Immunopathol; 1982; 5(2):175-92. PubMed ID: 6293112
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopathology of polyoma-induced tumors.
    Vandeputte M
    Springer Semin Immunopathol; 1982; 4(4):317-32. PubMed ID: 6293109
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activational signals for immune effector and suppressor T cells reactive with haptenic determinants.
    Tominaga A; Bromberg JS; Takaoki M; Lefort S; Noseworthy J; Benacerraf B; Greene MI
    Ann N Y Acad Sci; 1982; 392():309-17. PubMed ID: 6215883
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor growth and metastases in mice bearing a malignant fibrosarcoma by T cell-mediated immune response to oncofetal antigens.
    Gautam S; Deodhar SD
    Am J Reprod Immunol (1980); 1983; 3(3):141-8. PubMed ID: 6603172
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function.
    Palacios R; Guy K; Van Heyningen V
    Eur J Immunol; 1983 Jan; 13(1):64-72. PubMed ID: 6219882
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure of antigen-specific suppressor factors: current views.
    Kontiainen SK; James RF; Culbert EJ; Feldmann M
    Surv Immunol Res; 1982; 1(1):17-23. PubMed ID: 6195709
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of antitumor immunity--immunobiologic approaches.
    North RJ; Dye ES; Mills CD; Chandler JP
    Springer Semin Immunopathol; 1982; 5(2):193-220. PubMed ID: 6293113
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic mechanisms in UV radiation carcinogenesis.
    Kripke ML
    Adv Cancer Res; 1981; 34():69-106. PubMed ID: 6456650
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultraviolet light, tumors, and suppressor T cells.
    Spellman CW; Daynes RA
    Hum Pathol; 1981 Apr; 12(4):299-301. PubMed ID: 6165667
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for two functionally distinct cross-reactive tumor antigens associated with ultraviolet light and chemically induced tumors.
    Roberts LK; Lynch DH; Daynes RA
    Transplantation; 1982 Apr; 33(4):352-60. PubMed ID: 6176053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular sensitization to fetal antigens during chemical carcinogenesis].
    Pasternak G; Schlott B; Gryschek G; von Broen B; Albrecht S; Reinhöfer J
    Biomed Biochim Acta; 1983; 42(6):777-84. PubMed ID: 6639648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function.
    Trial J; Kapp JA; Pierce CW; Shreffler DC; Sorensen CM; Waltenbaugh C
    J Immunol; 1983 Feb; 130(2):565-72. PubMed ID: 6217244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
    Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
    Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the immune response T-cell interactions.
    Dutton RW; Swain SL
    CRC Crit Rev Immunol; 1982 Feb; 3(3):209-61. PubMed ID: 6176399
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor growth and evasion of immune destruction: UV-induced tumors as a model.
    Mullen CA; Schreiber H
    Surv Immunol Res; 1985; 4(4):264-70. PubMed ID: 2941841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
    Weber B
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.